This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Plasmidfactory Gmbh + Co Kg, Qiagen Gmbh. Active years: 2003-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2010
Title: Erwin Flaschel: Innovator in Nucleic Acid Technologies
Introduction
Erwin Flaschel is a notable inventor based in Bielefeld, Germany. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid technologies. With a total of 2 patents, his work has implications for both pharmaceutical and technical applications.
Latest Patents
Flaschel's latest patents include a method for producing extra-chromosomal nucleic acid molecules. This invention involves breaking up microbial cells and separating cellular components, allowing for the release and purification of extra-chromosomal nucleic acids. His second patent focuses on the isolation of ccc plasmid DNA, which details a process for culturing bacterial transformants in a bioreactor under specific conditions to optimize biomass production and DNA isolation.
Career Highlights
Throughout his career, Erwin Flaschel has worked with prominent companies such as Qiagen GmbH and Plasmidfactory GmbH & Co. KG. His expertise in nucleic acid technologies has positioned him as a valuable asset in the biotechnology sector.
Collaborations
Flaschel has collaborated with notable professionals in his field, including Torsten Schmidt and Karl Friehs. These partnerships have further enhanced his research and development efforts.
Conclusion
Erwin Flaschel's innovative work in nucleic acid technologies has made a significant impact on the field. His patents and collaborations reflect his dedication to advancing scientific knowledge and applications in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
